Search

Search Results
Results 17381 - 17390 of 17458 for Depression
  • Kozenis
    Drug - 25 Mar 2022
    Consumer Medicine Information (CMI) about Kozenis intended for persons living in Australia.
  • Zanidip
    Drug - 13 Mar 2022
    Consumer Medicine Information (CMI) about Zanidip intended for persons living in Australia.
  • Zavesca
    Drug - 25 Feb 2022
    Consumer Medicine Information (CMI) about Zavesca (Miglustat 100 mg capsules) intended for persons living in Australia.
  • Invega Hafyera
    Drug - 23 Feb 2022
    Consumer Medicine Information (CMI) about Invega Hafyera intended for persons living in Australia.
  • Teveten
    Drug - 11 Feb 2022
    Consumer Medicine Information (CMI) about Teveten intended for persons living in Australia.
  • Aratac
    Drug - 25 Jan 2022
    Consumer Medicine Information (CMI) about Aratac (amiodarone hydrochloride) intended for persons living in Australia.
  • Moxicam Tablets
    Drug - 18 Jan 2022
    Consumer Medicine Information (CMI) about Moxicam Tablets (meloxicam) intended for persons living in Australia.
  • Lorviqua
    Drug - 23 Dec 2021
    Consumer Medicine Information (CMI) about Lorviqua intended for persons living in Australia.
  • Enerzair Breezhaler
    Drug - 23 Dec 2021
    Consumer Medicine Information (CMI) about Enerzair Breezhaler (Indacaterol / glycopyrronium / mometasone furoate) intended for persons living in Australia.
  • Metomax
    Drug - 10 Dec 2021
    Consumer Medicine Information (CMI) about Metomax (paracetamol & metoclopramide hydrochloride) intended for persons living in Australia.

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback